| Symbol: |
EPM2A
|
| Description: |
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) [Source:HGNC Symbol;Acc:3413]
|
| Location: |
Chr6:145822719-146057160[-]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:180
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| EPM2A |
NSC 685265 |
0.022 |
Down |
| EPM2A |
NSC 685283 |
0.02 |
Down |
| EPM2A |
3-Pyridinecarboxylic acid, 4-[2-cyano-2-(ethoxycarbonyl)-1- (2-phenyhydrazino)ethenyl]- |
0.002 |
Down |
| EPM2A |
Dipyrazolo[3,4-f:3',4'-g]-2-pyrindine-3,4(2H,5H)-dione, 2,5-diphenyl- |
0.006 |
Down |
| EPM2A |
4(3H)-Quinazolinone, 3-[[(2-nitrophenyl)methylene]amino]-2-phenyl- |
0.047 |
Up |
| EPM2A |
NSC 686428 |
0.034 |
Down |
| EPM2A |
NSC 686474 |
0.006 |
Up |
| EPM2A |
NSC 686659 |
0.027 |
Up |
| EPM2A |
Phosphorodiamidic acid, N,N-bis(2-bromoethyl)-, (1,4-dioxo-2-naphthalenyl)methyl ester |
0.018 |
Down |
| EPM2A |
NSC 688715 |
0.012 |
Down |
| EPM2A |
NSC 688895 |
0.003 |
Down |
| EPM2A |
NSC 689074 |
0.033 |
Up |
| EPM2A |
NSC 689298 |
0.03 |
Up |
| EPM2A |
NSC 689300 |
0.025 |
Up |
| EPM2A |
NSC 689409 |
0.033 |
Down |
Expression pattern: Sensitivity / Resistance
Total:12 Current:6
First Prev Next Last 
|
| SNP:
~ Export ~
|
Records:42
Total:3 Current:1
[First] [Prev]  Next Last 
|
| miRNA:
~ Export ~
|
Records:10
Total:1 Current:1
[First] [Prev] [Next] [Last]
|